The CoVPN’s mission is to fully characterize the safety, immunogenicity, and efficacy of COVID vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of COVID infections globally. As such, we welcome the ideas of the scientific community regarding new proposals for COVID vaccine studies that are not currently being planned or pursued. We also welcome proposals from investigators who would like to use our data and/or specimens collected in COVID clinical trials to answer questions related to vaccinology, immunology, or COVID.
To submit a proposal, please email us with your name, phone number, hypothesis, objectives, and a brief description of your concept. You will be contacted within two weeks of your proposal submission if we require more information. If further development is encouraged by CoVPN leadership, we will work with you to establish the appropriate team and guide you on moving the proposal forward.
If you have any questions, or you would like to send additional materials that require formatting, such as graphs or tables, please e-mail email@example.com.
Content last reviewed on December 3, 2021